BRIEF published on 02/12/2026 at 15:56, 3 months 4 days ago European Commission Approves Amgen's UPLIZNA® for Generalized Myasthenia Gravis European Commission Amgen UPLIZNA GMG CD19-targeted Therapy
BRIEF published on 02/12/2026 at 15:56, 3 months 4 days ago La Commission européenne approuve UPLIZNA® d'Amgen pour le traitement de la myasthénie grave généralisée Commission Européenne Amgen UPLIZNA GMG Thérapie Ciblée CD19
PRESS RELEASE published on 02/12/2026 at 15:51, 3 months 4 days ago EUROPEAN COMMISSION APPROVES AMGEN'S UPLIZNA® FOR GENERALIZED MYASTHENIA GRAVIS European Commission approves Amgen's UPLIZNA for Generalized Myasthenia Gravis. New targeted treatment option with twice-yearly dosing for gMG patients European Commission Treatment Amgen UPLIZNA Generalized Myasthenia Gravis
Published on 05/16/2026 at 01:15, 1 day 8 hours ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 1 day 9 hours ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 1 day 10 hours ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 1 day 10 hours ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 17 hours 18 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 1 day 13 hours ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day 15 hours ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 18 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 18 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 23 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 3 days ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days 15 hours ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES
